From the Journals

VA MRSA Prevention Initiative reports continued health care–associated infection declines


 

FROM THE AMERICAN JOURNAL OF INFECTION CONTROL

The U.S. Department of Veterans Affairs MRSA Prevention Initiative, implemented in October 2007, has shown progress at limiting health care–associated infections of methicillin-resistant Staphylococcus aureus through 2011 and 2012.

A new report published in the January 2017 issue of the American Journal of Infection Control tracks continued declines in infection through September 2015.

MRSA ©Photo Researchers/NHGRI
Martin E. Evans, MD, of the MRSA and Multi-Drug Resistant Organisms (MDRO) Prevention Office of the VA, and his coauthors reported these declines from a national database, comprising 127 acute care facilities, 22 spinal cord injury units, and 133 long-term care facilities (Am J Infect Control. 2017 Jan 1;45[1]:13-6).

Monthly rates of health care–associated infections fell significantly in all settings from October 2007 to September 2015: an 87% decrease in ICUs, 80.1% in non-ICUs, 80.9% in spinal cord injury units, and 49.4% in long-term care facilities (P for all less than .0001).

“The VA data suggest that active surveillance followed by contact precautions (with or without decolonization) may be most useful when MRSA [health care–associated infection] rates are unacceptably high (as they were in VA facilities during 2007) or to decrease infections in high-risk units such as ICUs,” Dr. Evans and his colleagues concluded.

Details about the implementation of the initiative were previously published in the New England Journal of Medicine in 2011, including the initiative’s goal to promote “a change in the institutional culture whereby infection control would become the responsibility of everyone who had contact with patients” (N Engl J Med. 2011;364:1419-30).

Dr. Evans and his colleagues had no relevant financial disclosures.

Recommended Reading

C. difficile risk linked to antibiotic use in prior hospital bed occupant
MDedge Internal Medicine
Diabetes, stroke linked to recurrent C. difficile
MDedge Internal Medicine
Treated bacteremia that clears, then recurs, termed ‘skip phenomenon’
MDedge Internal Medicine
‘Skip phenomenon’ could explain fluctuating positivity for S. aureus bacteremia
MDedge Internal Medicine
Continue DMARDs, biologics in RA surgery patients
MDedge Internal Medicine
Hypervirulent Mycobacterium clone infecting cystic fibrosis patients worldwide
MDedge Internal Medicine
Idle intravenous catheters are associated with preventable complications
MDedge Internal Medicine
When to discontinue contact precautions for patients with MRSA
MDedge Internal Medicine
Understanding SSTI admission, treatment crucial to reducing disease burden
MDedge Internal Medicine
AGA Clinical Practice Update: Endoscope reprocessing guidelines are an improvement
MDedge Internal Medicine